Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,946
datasets available to search
ShareScore release 0.9.0
Dataset results
5,946 results for “Type 2 diabetes”
A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
ClinicalTrials.gov study NCT04537923. IPD Sharing: YES. Countries: 16. Publications: 1.
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01930188. IPD Sharing: Not stated. Countries: 18. Publications: 16.
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
ClinicalTrials.gov study NCT01147250. IPD Sharing: Not stated. Countries: 49. Publications: 12.
Examination of Psychological Tools and Tracking in an Online Intervention for Type 2 Diabetes
ClinicalTrials.gov study NCT03037528. IPD Sharing: NO. Countries: 1. Publications: 1.
Effect of Whole Fruit on Glycemic Control in Adults With Type 2 Diabetes
ClinicalTrials.gov study NCT03758742. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01652729. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes
ClinicalTrials.gov study NCT00136916. IPD Sharing: Not stated. Countries: 4. Publications: 2.
A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)
ClinicalTrials.gov study NCT05823948. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
ClinicalTrials.gov study NCT01620489. IPD Sharing: Not stated. Countries: 6. Publications: 4.
A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy
ClinicalTrials.gov study NCT01649297. IPD Sharing: Not stated. Countries: 18. Publications: 1.
Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT03336528. IPD Sharing: YES. Countries: 1. Publications: 1.
A Psychological-behavioral Intervention for Physical Activity in Type 2 Diabetes
ClinicalTrials.gov study NCT03150199. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT03018938. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea
ClinicalTrials.gov study NCT02471404. IPD Sharing: Not stated. Countries: 5. Publications: 1.
An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00642278. IPD Sharing: Not stated. Countries: 13. Publications: 3.
Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00765817. IPD Sharing: Not stated. Countries: 6. Publications: 5.
Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT02461589. IPD Sharing: Not stated. Countries: 10. Publications: 1.
A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas
ClinicalTrials.gov study NCT00313313. IPD Sharing: Not stated. Countries: 13. Publications: 6.
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Empagliflozin in Chinese Female and Male Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01316341. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease
ClinicalTrials.gov study NCT01042977. IPD Sharing: Not stated. Countries: 10. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.